| 40861 |
A |
II |
2025/01/02
|
MATRIX PHARMACORP PRIVATE LTD |
ALPRAZOLAM USP (FORM-III) |
| 40865 |
A |
III |
2025/01/01
|
YANGZHONG HONGYUN PHARMACEUTICAL PACKAGING CO LTD |
INJECTION MOLDED PLASTIC CLOSURE SYSTEM |
| 41098 |
A |
II |
2025/01/01
|
STHREE CHEMICALS PRIVATE LTD |
TETRACAINE HYDROCHLORIDE |
| 41151 |
A |
II |
2024/12/31
|
MSN LIFE SCIENCES PRIVATE LTD |
SAMIDORPHAN L-MALATE |
| 41157 |
A |
II |
2024/12/31
|
OPTIMUS DRUGS PRIVATE LTD |
LINEZOLID USP (FORM-III) |
| 40799 |
A |
II |
2024/12/31
|
DR REDDYS LABORATORIES LTD |
ABEMACICLIB |
| 40894 |
A |
II |
2024/12/31
|
CIPLA LTD |
OMEPRAZOLE USP PROCESS-II |
| 40932 |
A |
II |
2024/12/31
|
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTD |
BUPROPION HYDROBROMIDE |
| 40952 |
A |
II |
2024/12/31
|
HETERO DRUGS LTD |
ATOVAQUONE (FORM-A), PROCESS II
|
| 40974 |
A |
II |
2024/12/31
|
JIANGSU NHWA PHARMACEUTICAL CO LTD |
BUSPIRONE HYDROCHLORIDE USP |
| 40977 |
A |
II |
2024/12/31
|
EMCURE PHARMACEUTICALS LTD |
HYDROXYZINE PAMOATE USP |
| 40982 |
A |
II |
2024/12/31
|
HETERO DRUGS LTD |
RIFAXIMIN |
| 41007 |
A |
II |
2024/12/31
|
ALEMBIC PHARMACEUTICALS LTD |
RIFAXIMIN |
| 41012 |
A |
II |
2024/12/31
|
BIOPHORE INDIA PHARMACEUTICALS PVT LTD |
RUXOLITINIB PHOSPHATE |
| 41013 |
A |
II |
2024/12/31
|
BIOPHORE INDIA PHARMACEUTICALS PVT LTD |
NAPHAZOLINE NITRATE |
| 41014 |
A |
II |
2024/12/31
|
BIOPHORE INDIA PHARMACEUTICALS PVT LTD |
ASCIMINIB HYDROCHLORIDE PREMIX |
| 41026 |
A |
II |
2024/12/31
|
DR REDDYS LABORATORIES LTD |
VOCLOSPORIN |
| 41051 |
A |
II |
2024/12/31
|
ZHEJIANG HENGKANG PHARMACEUTICAL CO LTD |
DEFERASIROX |
| 41064 |
A |
IV |
2024/12/31
|
ZHEJIANG AUSUN PHARMACEUTICAL CO LTD |
CALCIUM SACCHARATE |
| 41073 |
A |
II |
2024/12/31
|
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD |
SAXAGLIPTIN INTERMEDIATE SGA
|
请输入需要查询的关联主题/药物名称（英文），DMF持有人（英文），DMF号码